Home/Filings/4/0001567619-19-021910
4//SEC Filing

Gupta Neeraj 4

Accession 0001567619-19-021910

CIK 0001433714other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 8:14 PM ET

Size

24.4 KB

Accession

0001567619-19-021910

Insider Transaction Report

Form 4
Period: 2019-11-16
Gupta Neeraj
EVP, Engineering
Transactions
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2019-11-1620,750269,750 total
    Class B Common Stock (20,750 underlying)
  • Exercise/Conversion

    Class B Common Stock

    2019-11-16+3,125357,065 total
  • Exercise/Conversion

    Class B Common Stock

    2019-11-16+20,750389,065 total
  • Sale

    Class B Common Stock

    2019-11-18$1.34/sh21,973$29,536367,092 total
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2019-11-163,12515,625 total
    Class B Common Stock (3,125 underlying)
  • Exercise/Conversion

    Class B Common Stock

    2019-11-16+8,125365,190 total
  • Exercise/Conversion

    Class B Common Stock

    2019-11-16+25,000353,940 total
  • Exercise/Conversion

    Class B Common Stock

    2019-11-16+3,125368,315 total
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2019-11-1625,00075,000 total
    Class B Common Stock (25,000 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2019-11-168,12573,125 total
    Class B Common Stock (8,125 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2019-11-163,12534,375 total
    Class B Common Stock (3,125 underlying)
Footnotes (8)
  • [F1]Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
  • [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $1.27 to $1.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  • [F3]Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration.
  • [F4]1/4th of the RSUs vested on August 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F5]1/4th of the RSUs vested on March 7, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F6]1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F7]1/16th of the RSUs vested on November 16, 2018, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F8]1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

Documents

1 file

Issuer

CASTLIGHT HEALTH, INC.

CIK 0001433714

Entity typeother

Related Parties

1
  • filerCIK 0001752737

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 8:14 PM ET
Size
24.4 KB